|
|||||
|
|
CD34+ cell dose predicts costs after autologous peripheral blood stem cell transplantation for breast cancer |
|
| Authors: | Baron Frédéric Copizza Sandra Baudoux Etienne Jerusalem Guy Fillet Georges Beguin Yves |
| Abstract: | We assessed the effect of CD34+ cell dose on costs in breast cancer patients undergoing autologous peripheral blood stem cell (PBSC) transplantation. Mean hospitalization costs were 26,992.9+/-9582.9 for patients receiving a CD34+ cell dose <5 x 10(6) cells/kg versus 22,339.4+/- 5471.1 for those receiving >5 x 10(6) CD34+ cells/kg (p=0.0065). |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ | |